Lower urinary tract symptoms and erectile dysfunction: Epidemiology and treatment in the aging man

被引：13

作者：

Russell S. ^{[1
]}

McVary K.T. ^{[1
]}

机构：

[1] Department of Urology, Northwestern University Feinberg School of Medicine, Tarry Building, Room 16-749,303 East Chicago Avenue, Chicago, 60611, IL

来源：

Current Urology Reports | 2005年 / 6卷 / 6期

关键词：

Benign Prostatic Hyperplasia; Erectile Dysfunction; Finasteride; Lower Urinary Tract Symptom; Sexual Function;

D O I：

10.1007/s11934-005-0040-3

中图分类号：

学科分类号：

摘要：

Lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) are common urologic problems that are seen in the aging male population. Until recently, aging itself was considered the common link between ED and LUTS. However, recent studies have shown that the links between these two disease processes are much more complex and are possibly inter-related with a common mechanism. This newly recognized independent relationship between ED and LUTS has the potential to have a profound impact on the way we diagnose and treat these common urologic disorders. © 2005, Current Science Inc.

引用

页码：445 / 453

页数：8

共 52 条

[11]

Berry S.J., Coffey D.S., Walsh P.C., Ewing L.L., The development of human benign prostatic hyperplasia with age, J Urol, 132, pp. 474-479, (1984)

[12]

Grayhack J.T., McVary K.T., Kozlowski J.M., Benign prostatic hyperplasia, Adult and Pediatric Urology, (2001)

[13]

Guess H.A., Arrighi H.M., Metter E.J., Fozard J.L., Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia, Prostate, 17, pp. 241-246, (1990)

[14]

Logie J.W., Clifford G.M., Farmer R.D., Meesen B.P., Lower urinary tract symptoms suggestive of benign prostatic obstruction. Triumph: the role of general practice databases, Eur Urol, 39, pp. 42-47, (2001)

[15]

Kaplan S.A., Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function, Urology, 63, pp. 428-434, (2004)

[16]

Chai T.C., Belville W.D., McGuire E.J., Et al., Specificity of the American Urological Association Voiding Symptom Index: comparison of unselected and selected samples of both sexes, J Urol, 150, pp. 1710-1713, (1993)

[17]

Grayhack J.T., BPH: The scope of the problem, Cancer, 70, pp. 275-279, (1992)

[18]

Feldman H.A., Goldstein I., Hatzichristou D.G., Et al., Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study, J Urol, 151, pp. 54-61, (1994)

[19]

Carson C.C., Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat, and patient education, Int J Impot Res, 14, pp. S29-S34, (2002)

[20]

Braun M., Wassmer G., Klotz T., Et al., Epidemiology of erectile dysfunction: results of the ’Cologne Male Survey’, Int J Impot Res, 12, pp. 305-311, (2000)

← 1 2 3 4 5 6 →